Momentus Vigoride-5 Status Update #1

Vehicle commissioning operations under way

SAN JOSE, Calif.–(BUSINESS WIRE)–Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company that offers transportation and other in-space infrastructure services, today announced that its Vigoride-5 Orbital Service Vehicle launched on the SpaceX Transporter-6 mission on January 3 is in good health and that the team is continuing to fully commission the vehicle in preparation for on-orbit operations. The Company has requested a Special Temporary Authority (STA) to continue operating the UHF beacon on Vigoride-5 for an additional 14 days to continue to track the vehicle during the commissioning phase and conduct testing to improve quality of the reception of the GPS data in the beacon signal. On Vigoride’s first orbital pass, Momentus confirmed that both solar arrays were deployed, and the vehicle was generating power and charging its batteries. The vehicle’s power and temperatures continue to be within the nominal expected ranges. Read more about the Vigoride-5 mission objectives and customers here.

About Momentus

Momentus is a U.S. commercial space company that offers in-space infrastructure services, including in-space transportation, hosted payloads and in-orbit services. Momentus believes it can make new ways of operating in space possible with its in-space transfer and service vehicles that will be powered by an innovative water plasma-based propulsion system that is under development.

Forward-Looking Statements

This press release contains certain statements which may constitute “forward-looking statements” for purposes of the federal securities laws. Forward-looking statements include, but are not limited to, statements regarding Momentus or its management team’s expectations, hopes, beliefs, intentions or strategies regarding the future, projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, and are not guarantees of future performance. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Momentus’ control. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to risks and uncertainties included under the heading “Risk Factors” in the Annual Report on Form 10-K filed by the Company on March 9, 2022, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the “SEC”), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at investors.momentus.space. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

Contacts

Investors

Darryl Genovesi at [email protected]

Media

Jessica Pieczonka at [email protected]

Read Previous

Medix Infusion Secures $35 Million in Series B Led by Echo Health Ventures

Read Next

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Core Scientific, Inc. (CORZ) Investors and Encourages Investors to Contact the Firm Before January 13, 2022

Leave a Reply

Most Popular

Please turn AdBlock off